{
    "Trade/Device Name(s)": [
        "Gmate\u00ae Origin Blood Glucose Monitoring System",
        "Gmate\u00ae Blood Glucose Test Strips",
        "Gmate\u00ae Origin Blood Glucose Meter",
        "Gmate\u00ae Control Solution"
    ],
    "Submitter Information": "Philosys, Inc.",
    "510(k) Number": "K151658",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083468",
        "K131230"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "October 14, 2015",
    "Summary Letter Received Date": "October 15, 2015",
    "Submission Date": "June 16, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Gmate\u00ae Origin Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical",
        "Glucose oxidase enzyme"
    ],
    "Methodologies": [
        "Quantitative glucose measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Gmate\u00ae Origin Blood Glucose Monitoring System for quantitative glucose measurement in capillary whole blood using electrochemical detection.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from various sites for self-testing by individuals with diabetes at home, not for diagnosis or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}